腹股沟下血管腔内干预后30天非计划再入院的风险因素
本研究基于2012至2014年美国外科医师学会国家手术质量改进项目靶向血管模块数据,纳入4449例腹股沟下血管腔内干预患者,其中2802例(63%)为慢性肢体威胁性缺血(CLI),1647例(37%)为间歇性跛行。CLI和跛行患者的非计划再入院率分别为16%和6.5%,再入院者死亡率更高;多因素logistic回归识别出糖尿病、充血性心力衰竭、肾功能不全、透析、胫动脉球囊扩张/支架植入、院内出血、非计划重返手术室及非家庭出院等风险因素。
要点
- CLI患者再入院率16%高于跛行患者6.5%,再入院者死亡率显著更高(CLI 3.4% vs 0.7%,跛行 2.8% vs 0.1%)。
- 约50%的非计划再入院与索引手术相关,CLI以伤口或感染为主(42%),跛行以周围血管病症状复发为主(28%)。
- CLI与跛行患者中糖尿病、透析、院内出血及非计划重返手术室均为再入院风险因素。
核心结论
- 腹股沟下血管腔内治疗后非计划再入院较常见,尤其在CLI患者中,并与死亡率显著增加相关。
- 识别上述风险因素有助于筛查高危患者,早期监测及预防术后并发症可能降低再入院率。
研究设计与样本
- 回顾性队列研究,基于美国外科医师学会国家手术质量改进项目(ACS NSQIP)靶向血管模块2012至2014年数据。
- 共纳入4449例腹股沟下血管腔内干预患者,其中CLI 2802例(63%),跛行1647例(37%)。
- 排除索引住院期间死亡及住院超过30天的患者,采用多因素logistic回归识别30天非计划再入院风险因素。
主要发现
- CLI患者非计划再入院率为16%(n=447),跛行患者为6.5%(n=107)。
- 再入院患者索引住院后死亡率高于未再入院者:CLI 3.4% vs 0.7%(P<.001),跛行 2.8% vs 0.1%(P<.01)。
- 约50%的非计划再入院与索引手术相关;CLI以伤口或感染相关为主(42%),跛行以周围血管病症状复发为主(28%)。
关键数值与推荐
- CLI患者再入院预测因素:糖尿病(OR 1.3,95%CI 1.01-1.6)、充血性心力衰竭(OR 1.6,95%CI 1.1-2.5)、肾功能不全(OR 1.7,95%CI 1.3-2.2)、术前透析(OR 1.4,95%CI 1.02-1.9)。
- CLI患者再入院预测因素:胫动脉球囊扩张/支架植入(OR 1.3,95%CI 1.04-1.6)、院内出血(OR 1.9,95%CI 1.04-3.5)、院内非计划重返手术室(OR 1.9,95%CI 1.1-3.5)、非家庭出院(OR 1.5,95%CI 1.1-2.0)。
- 跛行患者再入院风险因素:依赖功能状态(OR 3.5,95%CI 1.4-8.7)、吸烟(OR 1.6,95%CI 1.02-2.5)、糖尿病(OR 1.5,95%CI 1.01-2.3)、术前透析(OR 3.6,95%CI 1.6-8.3)。
- 跛行患者再入院风险因素:手术时间超过120分钟(OR 1.8,95%CI 1.1-2.7)、院内出血(OR 2.9,95%CI 1.2-7.4)、院内非计划重返手术室(OR 3.4,95%CI 1.2-9.4)。
临床怎么用
- 对具有糖尿病、心力衰竭、肾功能不全、透析、依赖功能状态等风险因素的患者加强术后早期监测。
- 关注术中及术后并发症如出血、非计划重返手术室,采取预防措施可能降低再入院风险。
- 对非家庭出院者应加强出院规划与随访,以降低再入院可能。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Unplanned hospital readmissions following surgical interventions are associated with adverse events and contribute to increasing health care costs. Despite numerous studies defining risk factors following lower extremity bypass surgery, evidence regarding readmission after endovascular interventions is limited. This study aimed to identify predictors of 30-day unplanned readmission following infrainguinal endovascular interventions. METHODS: We identified all patients undergoing an infrainguinal endovascular intervention in the targeted vascular module of the American College of Surgeons National Surgical Quality Improvement Program between 2012 and 2014. Perioperative outcomes were stratified by symptom status (chronic limb-threatening ischemia [CLI] vs claudication). Patients who died during index admission and those who remained in the hospital after 30 days were excluded. Indications for unplanned readmission related to the index procedure were evaluated. Multivariable logistic regression was used to identify preoperative and in-hospital (during index admission) risk factors of 30-day unplanned readmission. RESULTS: There were 4449 patients who underwent infrainguinal endovascular intervention, of whom 2802 (63%) had CLI (66% tissue loss) and 1647 (37%) had claudication. The unplanned readmission rates for CLI and claudication patients were 16% (n = 447) and 6.5% (n = 107), respectively. Mortality after index admission was higher for readmitted patients compared with those not readmitted (CLI, 3.4% vs 0.7% [P < .001]; claudication, 2.8% vs 0.1% [P < .01]). Approximately 50% of all unplanned readmissions were related to the index procedure. Among CLI patients, the most common indication for readmission related to the index procedure was wound or infection related (42%), whereas patients with claudication were mainly readmitted for recurrent symptoms of peripheral vascular disease (28%). In patients with CLI, predictors of unplanned readmission included diabetes (odds ratio, 1.3; 95% confidence interval, 1.01-1.6), congestive heart failure (1.6; 1.1-2.5), renal insufficiency (1.7; 1.3-2.2), preoperative dialysis (1.4; 1.02-1.9), tibial angioplasty/stenting (1.3; 1.04-1.6), in-hospital bleeding (1.9; 1.04-3.5), in-hospital unplanned return to the operating room (1.9; 1.1-3.5), and discharge other than to home (1.5; 1.1-2.0). Risk factors for those with claudication were dependent functional status (3.5; 1.4-8.7), smoking (1.6; 1.02-2.5), diabetes (1.5; 1.01-2.3), preoperative dialysis (3.6; 1.6-8.3), procedure time exceeding 120 minutes (1.8; 1.1-2.7), in-hospital bleeding (2.9; 1.2-7.4), and in-hospital unplanned return to the operating room (3.4; 1.2-9.4). CONCLUSIONS: Unplanned readmission after endovascular treatment is relatively common, especially in patients with CLI, and is associated with substantially increased mortality. Awareness of these risk factors will help providers identify patients at high risk who may benefit from early surveillance, and prophylactic measures focused on decreasing postoperative complications may reduce the rate of readmission.
引用
- Bodewes TC, Soden PA, Ultee KH, et al. Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions. J Vasc Surg. 2017. PMID: 28126175. doi:10.1016/j.jvs.2016.08.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。